Showing results (1201-1210 of 1,804) with videos related to
Sort By:
Pageof 181
Journal of Lipid Research|July 1, 1988
Similarity of unusual bile acids in human umbilical cord blood and amniotic fluid from newborns and in sera and urine from adult patients with cholestatic liver diseasesJ Shoda, R Mahara, T Osuga, et al.The Journal of Antibiotics|October 1, 1985
Lactoquinomycin, a novel anticancer antibiotic. I. Taxonomy, isolation and biological activityN Tanaka, T Okabe, F Isono, et al.Surgery Today|January 1, 1996
Composite carcinoid-adenocarcinoma tumor of the stomach: report of a caseS Nagaoka, H Toyoshima, T Bandoh, et al.Cancer Letters|April 1, 2008
Enhancement of cisplatin sensitivity and platinum uptake by 40 degrees C hyperthermia in resistant cellsT Ohtsubo, H Saito, N Tanaka, et al.Gastroenterology|June 1, 1997
Increased biliary group II phospholipase A2 and altered gallbladder bile in patients with multiple cholesterol stonesJ Shoda, T Ueda, T Ikegami, et al.Gan|April 1, 1983
Effects of human fibroblast interferon on human gliomas transplanted into nude miceN Tanaka, S Nagao, A Tohgo, et al.Chemical & Pharmaceutical Bulletin|September 1, 1994
Crude drugs from aquatic plants. IV. On the constituents of alismatis rhizoma. (2). Stereostructures of bioactive sesquiterpenes, alismol, alismoxide, orientalols A, B, and C, from Chinese alismatis rhizomaM Yoshikawa, S Yamaguchi, H Matsuda, et al.Nihon Hoigaku Zasshi = the Japanese Journal of Legal Medicine|April 1, 1994
[Recommendations for preventing transmission of infection with biohazard in the practice of legal medicine (2). Equipment and practical applications. The Medico-Legal Society of Japan, Committee on Expert Opinions]K Takahama, H Ishizu, S Oshida, et al.FEBS Letters|September 5, 1994
Interleukin 2-induced activation of JAK3: possible involvement in signal transduction for c-myc induction and cell proliferationH Asao, N Tanaka, N Ishii, et al.Infection and Immunity|August 1, 1994
Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated miceJ Fujii, T Kita, S Yoshida, et al.Pageof 181